Lung Ambition Awards

The Lung Ambition Awards, a joint initiative between Lung Cancer Canada, The Lung Ambition Alliance and AstraZeneca Canada, is a Canadian-based lung cancer research awards program designed to help improve the lives of people living with lung cancer.

​

As the program secretariat, Lung Cancer Canada will manage and administer the granting of the awards – the largest research award program of its kind in their 20-year history. To support the awards, AstraZeneca Canada has committed $100,000 per year for the next three years. This is the inaugural year of the program. The Lung Ambition Awards will award 2 - 3 research grants per year, with a maximum award of $50,000 CAD each. The review of submissions and selection of winners will be adjudicated solely by Lung Cancer Canada’s Research Committee. Winners will be chosen based on scientific merit, feasibility, and relevance to the Canadian lung cancer community.

​

The grant program is open to all Canadian clinicians and researchers (across the multi-disciplinary spectrum) who work in the lung cancer space.

​

Submissions will be accepted from November 1, 2023 to February 29, 2024. 

Winners will be announced in April of 2024.